Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$31.02 - $48.18 $4.03 Million - $6.26 Million
-130,000 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$41.14 - $56.98 $4.12 Million - $5.71 Million
100,249 Added 336.96%
130,000 $6.06 Million
Q3 2021

Oct 28, 2021

BUY
$35.31 - $50.56 $1.05 Million - $1.5 Million
29,751 New
29,751 $1.51 Million
Q2 2021

Aug 03, 2021

SELL
$25.8 - $41.09 $5.12 Million - $8.15 Million
-198,312 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$25.8 - $32.39 $3.96 Million - $4.97 Million
153,312 Added 340.69%
198,312 $5.59 Million
Q3 2020

Nov 03, 2020

BUY
$27.5 - $39.61 $1.24 Million - $1.78 Million
45,000 New
45,000 $1.39 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Yong Rong (Hk) Asset Management LTD Portfolio

Follow Yong Rong (Hk) Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.